Neuron23® Inc., a clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, today announced that data from the ...

An international research team has conceived a dual-component controller for three-phase inverters that can reportedly ...

Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219 SYX-5219 is a ...

Pierre Noé, Stéphane Malhouitre, and Benoît Charbonnier, discuss phase change materials for reconfigurable photonic ...

In Malaysia, the country’s public broadcaster, Radio Television of Malaysia, is using modulation monitors and rebroadcast ...

Discover the all-new Serum 2 synthesizer by Xfer Records, featuring advanced sound design tools and a free upgrade for existing users.

EBX-102-02 demonstrated clinically meaningful superiority over placebo in key efficacy assessments in patients with moderate to severe IBS-C ...

The sequel to Xfer Records' wildly popular synth plugin has finally been released after more than a decade of anticipation, bringing new synth engines, effects, a clip sequencer, built-in arpeggiator ...

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to ...